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The implementation of research findings into healthcare practice has become increasingly recognised as a major
priority for researchers, service providers, research funders and policymakers over the past decade. Nine years
after its establishment, Implementation Science, an international online open access journal, currently publishes
over 150 articles each year. This is fewer than 30% of those submitted for publication. The majority of manuscript
rejections occur at the point of initial editorial screening, frequently because we judge them to fall outside of
journal scope. There are a number of common reasons as to why manuscripts are rejected on grounds of scope.
Furthermore, as the field of implementation research has evolved and our journal submissions have risen, we
have, out of necessity, had to become more selective in what we publish. We have also expanded our scope,
particularly around patient-mediated and population health interventions, and will monitor the impact of such
changes. We hope this editorial on our evolving priorities and common reasons for rejection without peer review
will help authors to better judge the relevance of their papers to Implementation Science.
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The implementation of research findings into practice
has become increasingly recognised as a major priority
for researchers, research funders and policymakers over
the past decade [1-3]. Nine years after its establishment,
Implementation Science currently publishes over 150 ar-
ticles each year. This is fewer than 30% of those submit-
ted for publication. The majority of manuscript
rejections occur at the point of initial editorial screening,
frequently because we judge them to fall outside of jour-
nal scope. There are a number of common reasons as to
why manuscripts are rejected on grounds of scope.
However, as the field of implementation research has
evolved and our journal submissions have risen, we have
also, out of necessity, had to become more selective in
what we publish. This partly reflects our strategy for sus-
tainable growth: despite being an open access journal
with potentially infinite space for publishing articles, we
inevitably have limited editorial and reviewer resources.
We therefore need to prioritise manuscripts which can* Correspondence: r.foy@leeds.ac.uk
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unless otherwise stated.potentially make significant contributions to knowledge,
methodology or thinking—and aim to provide high qual-
ity support to both authors and reviewers to achieve
this.
Emerging issues and developments
Following discussions within our editorial team and con-
sultations with our Editorial Board and Senior Advisory
Board, we take this opportunity to reappraise our mission
and update our scope last set out in 2012 [4,5]. Emerging
issues and developments include the following:
 Extension of our field of interest, which
predominantly has been evidence-based healthcare
practice, to include evidence-based population
health;
 Recognition of a continuum between studies of
clinical or population interventions and studies of
implementation interventions, and the need to
clarify boundaries for journal scope;
 Prioritisation of studies which make substantial,
rather than marginal, contributions to the field of
implementation research.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Implementation Science is an open access, peer-reviewed
online journal that aims to publish research relevant to
promoting the uptake of research findings into health-
care practice and health policy.
Health and healthcare research constantly produce new
findings—but often these are not routinely translated into
practice. This loss in translation represents part of a wider
problem of systemic ‘research waste’ in the production
and reporting of research evidence [6,7]. Implementation
research is the scientific study of methods to promote the
systematic uptake of evidence-based interventions into
practice and policy and hence improve health. In this con-
text, it includes the study of influences on professional,
patient and organisational behaviour in healthcare, com-
munity or population contexts.
The lack of routine uptake of research findings is stra-
tegically important for the efforts to improve health and
healthcare because it places an invisible ceiling on the
potential for research to enhance population outcomes.
Further, it is scientifically important because it identifies
the behaviour of patients, professionals, organisations
and systems as key sources of variance requiring im-
proved empirical and theoretical understanding before
effective uptake can be reliably achieved.
Implementation science is an inherently interdisciplin-
ary research area, and the journal is not constrained by
any particular research method. Implementation Science
wishes to publish articles of high scientific rigour using
the most appropriate methods to produce valid, generalis-
able answers to research questions. As well as hosting
papers describing the effectiveness and economics of im-
plementation interventions, Implementation Science pro-
vides a unique home for articles describing intervention
development, evaluations of processes by which effects are
achieved and sustained and the role of theory relevant to
implementation research. The journal is interested in pub-
lishing articles that present novel methods (particularly
those that have a sound theoretical basis or offer design
advantages) for studying the determinants, processes and
effects of implementation interventions. We are also inter-
ested in receiving articles that report methodologically ro-
bust studies of the de-implementation of ineffective or
harmful practices.
We welcome study protocols, but typically we will only
consider these if the study has received ethical approval
by a recognised institutional body and been through ex-
ternal peer review via an established national or inter-
national funding body. We do not consider protocols for
systematic reviews or protocols for quantitative studies
that have begun data cleaning or analysis.
We expect authors to follow relevant reporting guide-
lines for studies to help ensure the transparency and
quality of our publications [8].Alongside elaborating issues we are particularly inter-
ested in, we take this opportunity to address a number
of common specific content and methodological matters
that lead us to reject a paper submitted to Implementa-
tion Science.Is it implementation research?
We initially assess whether submitted papers deal with
investigating, as opposed to conducting, implementation.
We expect studies to include a clear scientific question
and use an appropriate design, which can answer that
question. For example, we generally reject descriptive re-
ports of quality improvement initiatives. We aim to pri-
oritise manuscripts that offer significant contributions to
knowledge, methodology or thinking within the imple-
mentation science field.
We are interested in studies examining the implemen-
tation of evidence-based practices or policies or the de-
implementation of those demonstrated to be relatively
ineffective or even harmful [9]. We expect authors to in-
clude a brief summary of the existing evidence base for
any practice or policy being implemented, preferably
drawing upon systematic reviews and meta-analyses or
rigorous primary empirical studies.
We publish studies which evaluate clearly defined im-
plementation interventions but not studies testing novel
clinical or population health interventions. We often
find it difficult to judge whether evaluations of novel or-
ganisational or service delivery methods are within
scope, for example, variants of collaborative care for de-
pression often combine implementation and clinical
components [10]. We therefore continue to judge such
submissions on a case-by-case basis. However, we advise
authors to draw upon an existing taxonomy for defining
and describing interventions, such as that set out by the
Cochrane Collaboration Effective Practice and Organisa-
tion of Care Group [11]. We recognise that many imple-
mentation interventions are relatively complex and may
possess interacting components, target different behav-
iours, groups, organisational levels and outcomes, and
require degrees of tailoring [12].Scope and boundaries related to article type
Theories and frameworks
We welcome studies building and advancing theories
and frameworks relevant to implementation, preferably
through empirical testing. There is no shortage of such
frameworks and theories, many of which are poorly con-
ceptualised or have not been tested [13]. We often re-
ceive manuscripts which set out new theories and
frameworks and usually reject those which do not expli-
citly acknowledge or build upon existing work.
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We publish systematic reviews, which may cover issues
such as the effects of implementation interventions and
influences on the uptake of evidence. We also consider
other types of reviews (e.g. rapid, realist or scoping) but
expect them to use systematic methods to identify stud-
ies and report methods, including strengths and limita-
tions, as transparently as traditional systematic reviews.
Evaluations of implementation interventions
We expect studies that evaluate effectiveness to use
rigorous experimental or quasi-experimental designs,
such as randomised controlled trials or interrupted
time-series analyses. We generally reject studies with
poorer internal validity, such as those using uncontrolled
before-after designs. We recognise that evaluations of
implementation interventions can use mixed methods
approaches, so that strong effectiveness evaluation de-
signs may be accompanied by carefully designed qualita-
tive or quantitative process evaluations which elucidate
mechanisms of action, identify contextual factors that
moderate their effects and provide insights into imple-
mentation processes. A considerable body of evidence
about the effects of implementation interventions now
exists, and we expect authors to cite existing systematic
reviews or primary studies as relevant.
We receive a number of submissions reporting ‘effect-
iveness-implementation hybrid design’ studies. Curran et
al. defined such studies as follows [14]:
‘An effectiveness-implementation hybrid design is one
that takes a dual focus a priori in assessing clinical ef-
fectiveness and implementation. We propose three hy-
brid types: (1) testing effects of a clinical intervention on
relevant outcomes while observing and gathering infor-
mation on implementation; (2) dual testing of clinical
and implementation interventions/strategies; and (3)
testing of an implementation strategy while observing
and gathering information on the clinical intervention’s
impact on relevant outcomes’.
Any good clinical or health services researcher would
naturally welcome research which anticipates or ad-
dresses likely future implementation issues as early as
possible in the development and evaluation of clinical
interventions. However, publishing earlier stage hybrid
designs would detract from our mission which focuses
on the implementation of interventions of demonstrated
effectiveness. We are generally interested in types 2 and
3 hybrid designs with a clear justification and major
element of implementation research. Therefore, we usu-
ally reject type 1 hybrid designs.
We also receive manuscripts reporting studies which
investigate the effectiveness of a healthcare intervention
of demonstrated effectiveness in one context and then
evaluate its effects in another context (e.g. differentsetting or patient population). However, we usually reject
such manuscripts, regarding them as essentially primary
effectiveness studies with little contribution to imple-
mentation theory or research.
Economic evaluation
Although there is a large and growing evidence base re-
lating to the effectiveness of implementation strategies,
evidence evaluating their costs has been neglected [15].
Dissemination and implementation strategies are not
without costs and compete with other healthcare activity
for finite resources. We encourage submissions of em-
pirical studies which include an economic evaluation
component [16].
Process evaluations
We are interested in process evaluations of implementa-
tion interventions. We receive but are less interested in
process evaluations examining the implementation (or
fidelity) of clinical or population health interventions be-
ing evaluated within primary effectiveness studies. For
example, a process evaluation alongside a trial randomis-
ing individual patients in order to evaluate the effective-
ness of a form of counselling for depression would
generally fall outside of our scope. However, a process
evaluation alongside a cluster randomised trial evaluat-
ing the effects of a strategy to implement a form of
counselling for depression of known effectiveness would
come inside our scope.
We welcome process evaluations (qualitative, quantita-
tive or mixed methods) which can increase understanding
of a range of issues affecting the outcomes of effectiveness
studies, such as intervention uptake and adherence, influ-
ence of context, mechanisms of action and unintended
consequences [17]. We need to know the outcomes of the
associated effectiveness study so that readers can tell
whether a process evaluation aims to explain positive or
null outcomes. We typically reject process evaluations that
do not refer to the effectiveness study outcomes.
Qualitative studies
We frequently receive manuscripts using qualitative
methods for data collection and analysis of implementa-
tion research. We publish those that fit our scope and
meet applicable criteria for quality and validity. We usu-
ally reject qualitative studies where there are doubts
whether planned data saturation has been achieved and
single site case studies which limit typicality. We often
receive manuscripts that report on essentially content
analysis of interviews, without appropriate links to rele-
vant theory or without contextualisation and with little
reference to previous relevant qualitative studies or re-
views. We routinely reject these. There is a growing
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pect reference to those that are relevant.
Intervention development reports
We welcome reports of intervention development which
demonstrate novel methods, provide empirical or theor-
etical rationale for intervention content or offer content
of wider interest. We do not generally publish standa-
lone intervention development reports with no stated
intention to undertake a rigorous evaluation. We usually
reject reports describing interventions that are submit-
ted after the main evaluation results are known because
of the risks of post hoc rationalisation, whereby authors
may consciously or unintentionally modify intervention
content in light of study outcomes.
Protocols
These form a substantial proportion of our publications,
with randomised trials accounting for around half of our
published protocols. We receive and publish protocols
for a wide range of other designs, mainly mixed method,
qualitative and quasi-experimental studies, and for pro-
grammes of research. Protocol publication increases
transparency and acts as a guard against selective report-
ing, making it obvious if the research findings that are
published differ from what was initially planned [18].
Also, by providing information about research in progress,
protocol publication may reduce unplanned duplication of
effort and encourage greater information sharing and col-
laboration worldwide.
We usually accept (without further peer review) protocols
that have been through competitive peer review to receive
funding from a nationally or internationally recognised re-
search agency and that have received ethical review board
approval or exemption. Protocols for programmes of re-
search may be an exception to this requirement and are
considered on a case-by-case basis.
We do not usually accept:
 Protocols that have not been the subject of peer
review by a national or international research
agency;
 Protocols for quality improvement or service
evaluations, which lack a rigorous study design, such
as uncontrolled before-after studies;
 Protocols for pilot studies. Because pilot studies are
intended to lead on to subsequent, larger studies,
there will be considerable overlap between the
content of protocols for the two, and concerns
about duplicate publication then arise. Authors
should concentrate on publishing protocols for their
subsequent, larger studies;
 Protocols for systematic reviews. We usually refer
these to the BMC journal, Systematic Reviews; Protocols that are submitted for studies (particularly
randomised controlled trials) where data cleaning
and analysis have begun. Having a cut-off point
like this is a common requirement of journals that
publish trial protocols (in clinical trials, it is usually
the end of patient recruitment) so that publication
is a truly prospective event and the content of a
protocol cannot be influenced (however unlikely this
might be) by knowledge of the data. This may not
apply to some qualitative studies but, in general, the
intention is for a protocol to be published prior to
any analysis in order to prevent bias.
Authors of implementation trial protocols also need to
have registered the study with an appropriate trial data-
base and to complete an appropriate reporting guideline
checklist, such as the CONSORT extension to cluster
randomised trials [19]. We also now encourage authors
to ensure that protocol titles and abstracts include
clearly labelled study designs which can assist further
evidence syntheses.
Methodology
We welcome articles that present methods, which may
either be completely new, or offer an improvement to an
existing method. We favour submissions reporting em-
pirical comparisons of one or more methodological ap-
proaches or which clearly state what they add to existing
literature. We usually reject descriptive accounts of
largely established methods, such as manuscripts report-
ing the development of a specific clinical guideline with-
out any associated novel methodological insights.
Debate
We recognise the importance of debate and dialogue to
move the field of implementation research forward. We
welcome articles which question or challenge existing pol-
icies, practices, evidence or theory and suggest modifica-
tions or alternatives. However, as with other articles, we
expect authors to demonstrate how they build upon exist-
ing bodies of knowledge or methodology. We often reject
debate manuscripts which do not clearly articulate these,
as well as those that do not fully contextualise their dis-
cussion in the existing implementation research literature.
Within this category, we are interested in publishing
educational articles, particularly those that can inform
early career researchers about key conceptual and meth-
odological issues and therefore help develop capacity in
our field. We plan to publish a number of educational
articles for practitioners of implementation.
Short reports
We welcome brief reports of data from original research
which present relatively modest advances in knowledge
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Scope and boundaries related to article content
Potential significance of contribution to the literature
As highlighted earlier, we reject a large number of stud-
ies without peer review because they do not clearly ar-
ticulate their contribution to current evidence or appear
to make relatively minor contributions. This can be a
difficult judgement but is a task made easier for editors
and readers if authors clearly articulate what is already
known and what their work adds to existing knowledge,
theory and thinking. We plan to introduce a require-
ment that authors include such an explicit summary
statement for all research papers.
We aim to treat effectiveness studies equally regardless
of whether they report effects or no effects. We further
recognise the importance of attempts to replicate previous
findings, an objective which is often not sufficiently valued
in the dash for novelty. We therefore welcome replications
of implementation research accompanied by a clear ra-
tionale and will tend to reject those which are not.
We welcome studies on highly important but neglected
topics in healthcare or population health which make
more modest contributions to implementation research.
We are likely to reject submissions focused on a narrow
clinical domain or specific healthcare setting without a
convincing case for wider generalisation.
End-points of interest
If studies evaluating the effects of implementation inter-
ventions are to be of relevance to policy and practice,
they should have end-points related to evidence-based
processes of care, patient outcomes or population out-
comes. We receive submissions, sometimes as rando-
mised trials, which report proxy end-points, such as
beliefs and attitudes or unreliable measures such as self-
reported measures of professional practice. Such end-
points can have limited or low predictive validity; in
other words they may not lead to or represent changes
in actual behaviour. Naturally, similar measurement er-
rors may be true of other end-points, such as processes
of care or patient outcomes, which may not adequately
capture the evidence-based behaviour of interest. For ex-
ample, an increase in antidepressant prescribing does
not necessarily represent better clinical practice nor im-
prove patient outcomes—indeed, the opposite may be
true. Authors, therefore, need to make the case, or pro-
vide evidence for, the validity of study end-points. We
will however consider studies with proxy end-points pre-
sented as part of a programme of intervention development
work and which recognise the need for further evalu-
ation, such as explicitly theory-driven antecedents
of clinical behaviour. We are likely to reject studiesreporting proxy end-points which draw erroneous or
far-fetched conclusions about likely ‘real world’ effects
or are presented as standalone evaluations.
Population health interventions
We continue our interest in population (or public)
health papers evaluating the effectiveness of the intro-
duction of health-related practices of known effective-
ness. To date, we have usually limited this to public
health interventions involving healthcare settings or
healthcare professionals. However, the boundaries can
often become indistinct around, say, interventions tar-
geting trained lay health workers or interventions in
non-health settings, such as educational institutions. We
further recognise the importance of and our responsibility
to promote good science in improving population health.
We therefore welcome submissions on the scaling-up of
evidence-based population health interventions mediated
through agencies, technologies or networks, typically in-
volving healthcare providers but potentially others. We
are also interested in implementation questions focused
on national and local decision-makers and the implemen-
tation of interventions which connect people to resources
in the community (e.g. third sector). We are likely to re-
ject submissions on population health interventions where
effectiveness has not been demonstrated. We recognise
that the boundaries between what we consider to be im-
plementation research and relatively more upstream
population health research will remain challenging to dis-
tinguish. We will monitor this modification of scope and
suggest alternative journals to authors of papers that we
consider add more to fields other than implementation
research.
Patient-mediated interventions
We have had a long-running debate within our editorial
team on the boundaries around patient-mediated inter-
ventions [5]. We have hitherto welcomed studies in which
patients may directly influence the behaviour of healthcare
professionals in attempts to promote evidence-based prac-
tice. We have been less certain about studies of implemen-
tation interventions aimed directly at patients. This is
partly because it becomes increasingly difficult to draw
boundaries around such approaches which can, in effect,
be extensions of clinical or health promotion interven-
tions. However, if patients are acknowledged as key part-
ners in healthcare, they can logically also be the target of
implementation of evidence-based practice. We further
acknowledge that many interventions mainly targeted at
patients still require professional support [20]. Therefore,
we are interested in implementation strategies directly tar-
geting patients which also depend upon support from or
co-management with healthcare professionals. We are less
interested in studies exclusively focusing on influencing
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tively keep this extension of scope under review and
monitor the boundaries around studies of predominantly
clinical or health-promoting interventions.
Table 1 summarises issues that influence the likelihood
of rejection without review of articles submitted to Im-
plementation Science.
Current ambitions
Given the excellent submissions we receive, we are
confident that Implementation Science will continue to play
an important role in advancing the field. We have identi-
fied some specific needs and have published editorialsTable 1 Summary of issues that influence the likelihood of re
Implementation Science
Issue Likely to be accepted
Potential significance Work contextualised within existing im
research literature
Contribution to implementation resea
and potentially significant
Field of interest Healthcare and population health
Effectiveness studies Evaluating the effectiveness of implem
of an evidence-based practice or polic
de-implementation of those demonst
be relatively ineffective or even harmf
Outcome Health or health-related
Implementation Researching implementation
Validity Maximises internal and external validit
in the chosen study designs
Patient decision aids Evaluations of the implementation of
aids (of known effectiveness) into hea
involvement of healthcare providers
Implementation direct to patients Outcomes referring to evidence-based
some involvement of healthcare prov
Intervention development reports Prepared and submitted prior to the r
the effectiveness of the intervention
Going to be, (robustly) evaluated
Providing empirical and/or theoretical
Process evaluation Submitted contemporaneously with o
report of intervention effectiveness
Process evaluations that take account
main evaluation outcomes
Pilot studies If appropriate criteria for conduct
If appropriate degree of inference
If there are plans for further evaluation
Protocols Been through peer review by a nation
recognised research agency as part of
Received ethics review board approva
Submitted prior to data cleaning or anwelcoming further manuscripts on de-implementation and
economic evaluations [9,20]. We are keen to promote re-
search in low- and middle-income countries and in im-
portant but under-researched topics. We also wish to
publish more educational articles covering conceptual and
methodological issues which can promote capacity devel-
opment and more rigorous research.
We are grateful to our authors, reviewers and editors
who have contributed to our growth. We recognise that
we do not always get it right and hope to improve the
quality of our reviews and speed of turnaround. We will
continue to review and refine our policies as the journal
and the research field continue to evolve. We welcomejection without review of articles submitted to
Likely to be rejected
plementation Work not contextualised within existing
implementation research literature
rch articulated Contribution to implementation research
not articulated or relatively minor
Anything else
entation
y, or
rated to
ul
Evaluating the effectiveness of a clinical,
organisational, public health or policy intervention
Anything else
Doing implementation
y as appropriate
patient decision
lthcare settings;
Initial development, pilot testing or evaluation
of patient decision aids
practice with
iders
Other types of outcomes
eporting of Post hoc submission
Not going to be (robustly) evaluated
rationale
r following Process evaluations submitted in advance of the
conduct of the main effectiveness analysis (it
cannot be clear if they are explaining an effect
or the absence of an effect)
of the Process evaluations that do not take account
of the main evaluation outcomes
No justification for conduct
Overclaim on basis of results
ally
their funding
Not been through peer review by a nationally
recognised research agency as part of their funding
l Not received ethics review board approval
alysis Have begun data cleaning or analysis (may not
apply to some qualitative studies)
Foy et al. Implementation Science  (2015) 10:51 Page 7 of 7author and reader comments (submitted via the ‘Com-
ment’ facility associated with our articles) and debate to
guide our future development.
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